These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3829160)

  • 1. Stability of pilocarpine ophthalmic formulations.
    Yoshioka S; Aso Y; Shibazaki T; Uchiyama M
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4280-6. PubMed ID: 3829160
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of the ophthalmic therapeutic pilocarpine and its degradation products by reversed-phase high-performance liquid chromatography.
    Noordam A; Waliszewski K; Olieman C; Maat L; Beyerman HC
    J Chromatogr; 1978 Jun; 153(1):271-3. PubMed ID: 659559
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of pilocarpine and isopilocarpine in ophthalmic solutions by normal-phase high-performance liquid chromatography.
    Dunn DL; Scott BS; Dorsey ED
    J Pharm Sci; 1981 Apr; 70(4):446-9. PubMed ID: 7229964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of pilocarpine, isopilocarpine, pilocarpic acid, and isopilocarpic acid in clinical ophthalmic pilocarpine formulations by reversed-phase liquid chromatography.
    Noordam A; Maat L; Beyerman HC
    J Pharm Sci; 1981 Jan; 70(1):96-7. PubMed ID: 7229939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of pilocarpine and isopilocarpine by high performance liquid chromatography in normal phase. The stability of eye drops with a pilocarpine base and comparison of this method with a colorimetric method using hydroxylamine].
    Balansard G; Vidal E; Guigues M; Ollivier B; de Meo M
    Pharm Acta Helv; 1986; 61(2):47-50. PubMed ID: 3960937
    [No Abstract]   [Full Text] [Related]  

  • 6. Pilocarpine hydrochloride in ophthalmic solutions: modification of a high-pressure liquid chromatographic determination and survey.
    Weber JD
    J Assoc Off Anal Chem; 1976 Nov; 59(6):1409-15. PubMed ID: 993193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribtuion to the study of the stability of pilocarpine in aqueous medium. 3. Stability of ophthalmic solutions].
    Baeschlin K; Etter JC
    Pharm Acta Helv; 1969 Jun; 44(6):348-55. PubMed ID: 5805009
    [No Abstract]   [Full Text] [Related]  

  • 8. [The stability of pilocarpine hydrochloride in eyedrops].
    Porst H; Kny L
    Pharmazie; 1985 Jan; 40(1):23-9. PubMed ID: 3991781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sterilization by autoclaving on the stability of eye drops of pilocarpine hydrochloride and physostigmine sulphate.
    Mair AE; Miller JH
    J Clin Hosp Pharm; 1984 Sep; 9(3):217-24. PubMed ID: 6490942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decomposition of pilocarpine eye drops assessed by a highly efficient high pressure liquid chromatographic method.
    Kuks PF; Weekers LE; Goldhoorn PB
    Pharm Weekbl Sci; 1990 Oct; 12(5):196-9. PubMed ID: 2255589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of pilocarpine hydrochloride and pilocarpine nitrate ophthalmic solutions submitted by U.S. hospitals.
    Kreienbaum MA; Page DP
    Am J Hosp Pharm; 1986 Jan; 43(1):109-17. PubMed ID: 3953580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of commercial pilocarpine preparations by high-performance liquid chromatography.
    Drake MV; O'Donnell JJ; Sandman RP
    J Pharm Sci; 1982 Mar; 71(3):358-9. PubMed ID: 7069599
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of pilocarpine ophthalmic solutions.
    Pilatti C; Torre MC; Chiale C; Spinetto M
    Drug Dev Ind Pharm; 1999 Jun; 25(6):801-5. PubMed ID: 10349567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of pilocarpine, physostigmine, its degradation product rubreserine and preservatives by high-performance liquid chromatography.
    Kneczke M
    J Chromatogr; 1980 Oct; 198(4):529-33. PubMed ID: 7440688
    [No Abstract]   [Full Text] [Related]  

  • 15. [Stability and determination of pilocarpine in eyedrops].
    Jacob M; Duru M; Duru C
    Pharm Acta Helv; 1981; 56(2):59-63. PubMed ID: 7220561
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative analysis of degradation products in pilocarpine hydrochloride ophthalmic formulations.
    Neville GA; Hasan FB; Smith IC
    J Pharm Sci; 1977 May; 66(5):638-42. PubMed ID: 17713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of pilocarpine and its degradation products by micellar electrokinetic capillary chromatography.
    Charman WN; Humberstone AJ; Charman SA
    Pharm Res; 1992 Sep; 9(9):1219-23. PubMed ID: 1409408
    [No Abstract]   [Full Text] [Related]  

  • 18. High-performance liquid chromatographic analysis of pilocarpine hydrochloride, isopilocarpine, pilocarpic acid and isopilocarpic acid in eye-drop preparations.
    Kennedy JM; McNamara PE
    J Chromatogr; 1981 Aug; 212(3):331-8. PubMed ID: 7263802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-speed liquid chromatographic determination of pilocarpine in pharmaceutical dosage forms.
    Khalil SK
    J Pharm Sci; 1977 Nov; 66(11):1625-6. PubMed ID: 915743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stability of some viscous collyria with alkaloids].
    Gaiţa G; Oiţă N; Murariu E; Lazăr M
    Rev Med Chir Soc Med Nat Iasi; 1977; 81(4):669-73. PubMed ID: 613419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.